IMVANEX

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom

Active ingredients

The drug IMVANEX contains one active pharmaceutical ingredient (API):

1 Smallpox, live attenuated UNII TU8J357395 - VACCINIA VIRUS MODIFIED STRAIN ANKARA-BAVARIAN NORDIC NON-REPLICATING ANTIGEN

Smallpox vaccine is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. Read about Smallpox, live attenuated

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IMVANEX Suspension for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BX01		J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BX Other viral vaccines
Discover more medicines within J07BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1621695
Country: FR	Base de données publique des médicaments	Identifier(s): 60215623
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 387752
Country: IT	Agenzia del Farmaco	Identifier(s): 042944013, 042944025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1071082
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100310921